42847922MDD3003 | Clinical Research Studies Listing

Recruiting

74 years or below

All

Phase N/A

6 participants needed

1 Location

Brief description of study

The study will investigate 20 mg seltorexant as adjunctive treatment to SSRI/SNRI antidepressants for major depressive disorder (MDD) compared with placebo as adjunctive therapy in patients with a partial response to first line antidepressant therapy.

Detailed description of study

To assess the efficacy of seltorexant 20 mg compared with placebo as adjunctive therapy to an SSRI/SNRI
antidepressant in improving depressive symptoms in participants with MDDIS who have had an inadequate response to current SSRI/SNRI antidepressant therapy

Eligibility of study

You may be eligible for this study if you meet the following criteria:

Conditions: Medical Research
Age: 74 years or below
Gender: All

Body mass index (BMI) between 18 and 40 kg/m2

Is receiving and tolerating well any one of the following SSRI or SNRI for depressive
symptoms at screening

Updated on 17 Jun 2025. Study ID: 24-0879

Find a site

Your Information has been sent successfully.

We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.

Would you like to be notified about other trials? Sign up for Patient Notification Services.

Send a message

Enter your contact details to connect with study team

View email

Phone

View phone

First name*

Last name*

Email*

Phone number*

Preferred way of contact

Please provide your preferred way of contact

Other language

By Submitting your information, you agree that your details may be shared with the selected study site and handled in accordance with this Website's Privacy Policy (see link in footer). You may be contacted by email, text message, or phone regarding this study and other research opportunities that may be of interested to you. You can unsubscribe from these communications at any time. Message and data rates may apply.

Interested in the study

Select a study center that’s convenient for you, and get in touch with the study team.

Contact a study center